Systemic Diseases in Primary Open-Angle Glaucoma

Abstract

Primary open-angle glaucoma is a neurodegenerative disease with progressive chronic optic neuropathy and corresponding visual field defects. In this literature review, we discuss systemic diseases and their mechanism for developing glaucoma, including systemic hypertension and hypotension, diabetes, dyslipidemia, obstructive sleep apnoea syndrome, chronic kidney disease, migraine, and polypharmacy.

Keywords

glaucoma - arterial hypertension - arterial hypotension - diabetes - migraine

Publikationsverlauf

Eingereicht: 26. Oktober 2023

Angenommen: 15. Dezember 2023

Artikel online veröffentlicht:
27. Februar 2024

• References/Literatur

• 1 Tham YC, Cheng CY. Associations between chronic systemic diseases and primary open angle glaucoma: an epidemiological perspective. Clin Exp Ophthalmol 2017; 45: 24-32 DOI: 10.1111/ceo.12763.
• 2 Claessen H, Kvitkina T, Narres M. et al. Markedly decreasing incidence of cause-specific blindness in Saxony (Eastern Germany). Graefes Arch Clin Exp Ophthalmol 2021; 259: 1089-1101 DOI: 10.1007/s00417-020-04885-4.
• 3 Huber M, Kölzsch M, Stahlmann R. et al. Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma. Drugs Aging 2013; 30: 31-38 DOI: 10.1007/s40266-012-0036-x.
• 4 [Anonymous] Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398: 957-980 DOI: 10.1016/s0140-6736(21)01330-1.
• 5 Mitchell P, Lee AJ, Rochtchina E. et al. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma 2004; 13: 319-326 DOI: 10.1097/00061198-200408000-00010.
• 6 Dielemans I, Vingerling JR, Algra D. et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995; 102: 54-60 DOI: 10.1016/s0161-6420(95)31054-8.
• 7 Sun J, Zhou X, Kang Y. et al. Prevalence and risk factors for primary open-angle glaucoma in a rural northeast China population: a population-based survey in Bin County, Harbin. Eye (Lond) 2012; 26: 283-291 DOI: 10.1038/eye.2011.243.
• 8 Wang S, Xu L, Jonas JB. et al. Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study. Ophthalmology 2009; 116: 2373-2380 DOI: 10.1016/j.ophtha.2009.05.041.
• 9 Zhao D, Cho J, Kim MH. et al. The association of blood pressure and primary open-angle glaucoma: a meta-analysis. Am J Ophthalmol 2014; 158: 615-627.9 DOI: 10.1016/j.ajo.2014.05.029.
• 10 Xu L, Wang H, Wang Y. et al. Intraocular pressure correlated with arterial blood pressure: the Beijing eye study. Am J Ophthalmol 2007; 144: 461-462 DOI: 10.1016/j.ajo.2007.05.013.
• 11 Flammer J, Orgül S, Costa VP. et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21: 359-393 DOI: 10.1016/s1350-9462(02)00008-3.
• 12 Van Eijgen J, Melgarejo JD, Van Laeken J. et al. The relevance of arterial blood pressure in the management of glaucoma progression: a systematic review. Am J Hypertens 2023; DOI: 10.1093/ajh/hpad111.
• 13 Tielsch JM, Katz J, Sommer A. et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995; 113: 216-221 DOI: 10.1001/archopht.1995.01100020100038.
• 14 Hayreh SS. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol 1999; 10: 474-482 DOI: 10.1097/00055735-199912000-00017.
• 15 Wong TY, Mitchell P. The eye in hypertension. Lancet 2007; 369: 425-435 DOI: 10.1016/s0140-6736(07)60198-6.
• 16 Memarzadeh F, Ying-Lai M, Chung J. et al. Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 2010; 51: 2872-2877 DOI: 10.1167/iovs.08-2956.
• 17 Grunwald JE, Piltz J, Hariprasad SM. et al. Optic nerve blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmol 1999; 127: 516-522 DOI: 10.1016/s0002-9394(99)00028-8.
• 18 Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol 1999; 43 (Suppl. 1) S10-S16 DOI: 10.1016/s0039-6257(99)00016-8.
• 19 Middeke M. Hypertonie: Die Krux der RR-Variabilität. Dtsch Arztebl 2014; 111: 4-8
• 20 Melgarejo JD, Eijgen JV, Wei D. et al. Effect of 24-h blood pressure dysregulations and reduced ocular perfusion pressure in open-angle glaucoma progression. J Hypertens 2023; 41: 1785-1792 DOI: 10.1097/hjh.0000000000003537.
• 21 Lin KY, Hsih WH, Lin YB. et al. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig 2021; 12: 1322-1325 DOI: 10.1111/jdi.13480.
• 22 Zhao D, Cho J, Kim MH. et al. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology 2015; 122: 72-78 DOI: 10.1016/j.ophtha.2014.07.051.
• 23 Li Y, Mitchell W, Elze T. et al. Association Between Diabetes, Diabetic Retinopathy, and Glaucoma. Curr Diab Rep 2021; 21: 38 DOI: 10.1007/s11892-021-01404-5.
• 24 Cohen E, Kramer M, Shochat T. et al. Relationship Between Serum Glucose Levels and Intraocular Pressure, a Population-based Cross-sectional Study. J Glaucoma 2017; 26: 652-656 DOI: 10.1097/ijg.0000000000000700.
• 25 Li Y, Mitchell W, Elze T. et al. Association Between Diabetes, Diabetic Retinopathy, and Glaucoma. Curr Diab Rep 2021; 21: 38 DOI: 10.1007/s11892-021-01404-5.
• 26 Wang Y, Fawzi AA, Varma R. et al. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci 2011; 52: 840-845 DOI: 10.1167/iovs.10-5985.
• 27 Dimitrova G, Chihara E, Takahashi H. et al. Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy. Invest Ophthalmol Vis Sci 2017; 58: 190-196 DOI: 10.1167/iovs.16-20531.
• 28 Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85-91 DOI: 10.7326/0003-4819-90-1-85.
• 29 Huang G, Wang J, Li L. et al. Meta-Analysis of Dyslipidemia and Blood Lipid Parameters on the Risk of Primary Open-Angle Glaucoma. Comput Math Methods Med 2022; 2022: 1122994 DOI: 10.1155/2022/1122994.
• 30 Nusinovici S, Li H, Thakur S. et al. High-Density Lipoprotein 3 Cholesterol and Primary Open-Angle Glaucoma: Metabolomics and Mendelian Randomization Analyses. Ophthalmology 2022; 129: 285-294 DOI: 10.1016/j.ophtha.2021.09.013.
• 31 Zeleznik OA, Kang JH, Lasky-Su J. et al. Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank. Nat Commun 2023; 14: 2860 DOI: 10.1038/s41467-023-38466-w.
• 32 Madjedi KM, Stuart KV, Chua SYL. et al. The Association between Serum Lipids and Intraocular Pressure in 2 Large United Kingdom Cohorts. Ophthalmology 2022; 129: 986-996 DOI: 10.1016/j.ophtha.2022.04.023.
• 33 Pertl L, Mossböck G, Wedrich A. et al. Triglycerides and Open Angle Glaucoma – A Meta-analysis with meta-regression. Sci Rep 2017; 7: 7829 DOI: 10.1038/s41598-017-08295-1.
• 34 Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014; 383: 736-747 DOI: 10.1016/s0140-6736(13)60734-5.
• 35 Chaitanya A, Pai VH, Mohapatra AK. et al. Glaucoma and its association with obstructive sleep apnea: A narrative review. Oman J Ophthalmol 2016; 9: 125-134 DOI: 10.4103/0974-620x.192261.
• 36 Shi Y, Liu P, Guan J. et al. Association between glaucoma and obstructive sleep apnea syndrome: a meta-analysis and systematic review. PLoS One 2015; 10: e0115625 DOI: 10.1371/journal.pone.0115625.
• 37 Liu S, Lin Y, Liu X. Meta-Analysis of Association of Obstructive Sleep Apnea With Glaucoma. J Glaucoma 2016; 25: 1-7 DOI: 10.1097/ijg.0000000000000357.
• 38 Cheong AJY, Wang SKX, Woon CY. et al. Obstructive sleep apnoea and glaucoma: a systematic review and meta-analysis. Eye (Lond) 2023; 37: 3065-3083 DOI: 10.1038/s41433-023-02471-6.
• 39 Wu X, Liu H. Obstructive sleep apnea/hypopnea syndrome increases glaucoma risk: evidence from a meta-analysis. Int J Clin Exp Med 2015; 8: 297-303
• 40 Girkin CA, McGwin jr. G, McNeal SF. et al. Is there an association between pre-existing sleep apnoea and the development of glaucoma?. Br J Ophthalmol 2006; 90: 679-681 DOI: 10.1136/bjo.2005.086082.
• 41 Muniesa M, Sánchez-de-la-Torre M, Huerva V. et al. Floppy eyelid syndrome as an indicator of the presence of glaucoma in patients with obstructive sleep apnea. J Glaucoma 2014; 23: e81-e85 DOI: 10.1097/IJG.0b013e31829da19f.
• 42 Fan YY, Su WW, Liu CH. et al. Correlation between structural progression in glaucoma and obstructive sleep apnea. Eye (Lond) 2019; 33: 1459-1465 DOI: 10.1038/s41433-019-0430-2.
• 43 Kiekens S, De Groot V, Coeckelbergh T. et al. Continuous positive airway pressure therapy is associated with an increase in intraocular pressure in obstructive sleep apnea. Invest Ophthalmol Vis Sci 2008; 49: 934-940 DOI: 10.1167/iovs.06-1418.
• 44 Ng FYC, Song H, Tan BKJ. et al. Bidirectional association between glaucoma and chronic kidney disease: A systematic review and meta-analysis. EClinicalMedicine 2022; 49: 101498 DOI: 10.1016/j.eclinm.2022.101498.
• 45 Cho HK, Han JC, Choi JA. et al. Association Between Chronic Renal Disease and the Risk of Glaucoma Development: A 12-year Nationwide Cohort Study. Invest Ophthalmol Vis Sci 2021; 62: 27 DOI: 10.1167/iovs.62.6.27.
• 46 Tham YC, Tao Y, Zhang L. et al. Is kidney function associated with primary open-angle glaucoma? Findings from the Asian Eye Epidemiology Consortium. Br J Ophthalmol 2020; 104: 1298-1303 DOI: 10.1136/bjophthalmol-2019-314890.
• 47 Tham YC, Lim SH, Gupta P. et al. Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: the Singapore Epidemiology of Eye Diseases study. Br J Ophthalmol 2018; 102: 1402-1406 DOI: 10.1136/bjophthalmol-2017-311359.
• 48 Holappa M, Vapaatalo H, Vaajanen A. Many Faces of Renin-angiotensin System – Focus on Eye. Open Ophthalmol J 2017; 11: 122-142 DOI: 10.2174/1874364101711010122.
• 49 Izzotti A, Bagnis A, Saccà SC. The role of oxidative stress in glaucoma. Mutat Res 2006; 612: 105-114 DOI: 10.1016/j.mrrev.2005.11.001.
• 50 Lv W, Booz GW, Fan F. et al. Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies. Front Physiol 2018; 9: 105 DOI: 10.3389/fphys.2018.00105.
• 51 Nongpiur ME, Wong TY, Sabanayagam C. et al. Chronic kidney disease and intraocular pressure: the Singapore Malay Eye Study. Ophthalmology 2010; 117: 477-483 DOI: 10.1016/j.ophtha.2009.07.029.
• 52 Hu J, Bui KM, Patel KH. et al. Effect of hemodialysis on intraocular pressure and ocular perfusion pressure. JAMA Ophthalmol 2013; 131: 1525-1531 DOI: 10.1001/jamaophthalmol.2013.5599.
• 53 Lee JY, Kim JM, Shim SH. et al. Association Between Optic Disc Hemorrhage and Renal Function in South Korea. J Glaucoma 2018; 27: 251-256 DOI: 10.1097/ijg.0000000000000871.
• 54 Wang YC, Ling XC, Tsai WH. et al. Risks of Topical Carbonic Anhydrase Inhibitors in Glaucoma Patients With Chronic Kidney Disease: A Nationwide Population-Based Study. Am J Ophthalmol 2023; 253: 49-55 DOI: 10.1016/j.ajo.2023.05.007.
• 55 Stewart WF, Wood C, Reed ML. et al. Cumulative lifetime migraine incidence in women and men. Cephalalgia 2008; 28: 1170-1178 DOI: 10.1111/j.1468-2982.2008.01666.x.
• 56 Breslau N, Rasmussen BK. The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology 2001; 56 (6 Suppl. 1): S4-S12 DOI: 10.1212/wnl.56.suppl_1.s4.
• 57 Bashir A, Lipton RB, Ashina S. et al. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology 2013; 81: 1260-1268 DOI: 10.1212/WNL.0b013e3182a6cb32.
• 58 Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 2010; 9: 309-317 DOI: 10.1016/s1474-4422(09)70358-8.
• 59 Gramer G, Weber BH, Gramer E. Migraine and Vasospasm in Glaucoma: Age-Related Evaluation of 2027 Patients With Glaucoma or Ocular Hypertension. Invest Ophthalmol Vis Sci 2015; 56: 7999-8007 DOI: 10.1167/iovs.15-17274.
• 60 Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain 2013; 154 (Suppl. 1) S44-S53 DOI: 10.1016/j.pain.2013.07.021.
• 61 Klein BE, Klein R, Meuer SM. et al. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1993; 34: 3024-3027
• 62 Wang JJ, Mitchell P, Smith W. Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountains Eye Study. Ophthalmology 1997; 104: 1714-1719 DOI: 10.1016/s0161-6420(97)30075-x.
• 63 Huang JY, Su CC, Wang TH. et al. Migraine and increased risk of developing open angle glaucoma: a population-based cohort study. BMC Ophthalmol 2019; 19: 50 DOI: 10.1186/s12886-019-1062-9.
• 64 Xu C, Li J, Li Z. et al. Migraine as a risk factor for primary open angle glaucoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018; 97: e11377 DOI: 10.1097/md.0000000000011377.
• 65 Wu A, Khawaja AP, Pasquale LR. et al. A review of systemic medications that may modulate the risk of glaucoma. Eye (Lond) 2020; 34: 12-28 DOI: 10.1038/s41433-019-0603-z.
• 66 Zheng W, Dryja TP, Wei Z. et al. Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma. Ophthalmology 2018; 125: 984-993 DOI: 10.1016/j.ophtha.2018.01.007.
• 67 Wettrell K, Pandolfi M. Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers. Exp Eye Res 1975; 21: 451-456 DOI: 10.1016/0014-4835(75)90126-8.
• 68 Ho H, Shi Y, Chua J. et al. Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study. JAMA Ophthalmol 2017; 135: 196-202 DOI: 10.1001/jamaophthalmol.2016.5318.
• 69 Kim J, Kennedy Neary MT, Aschard H. et al. Statin Use in Relation to Intraocular Pressure, Glaucoma, and Ocular Coherence Tomography Parameters in the UK Biobank. Invest Ophthalmol Vis Sci 2022; 63: 31 DOI: 10.1167/iovs.63.5.31.
• 70 Vergroesen JE, Schuster AK, Stuart KV. et al. Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium. Ophthalmology 2023; 130: 893-906 DOI: 10.1016/j.ophtha.2023.05.001.
• 71 Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999; 341: 1447-1457 DOI: 10.1056/nejm199911043411907.
• 72 Osborne NN, Casson RJ, Wood JP. et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004; 23: 91-147 DOI: 10.1016/j.preteyeres.2003.12.001.
• 73 Araie M, Mayama C. Use of calcium channel blockers for glaucoma. Prog Retin Eye Res 2011; 30: 54-71 DOI: 10.1016/j.preteyeres.2010.09.002.